[1] Perry DJ, Noakes TJ, Helliwell PS. (2007) Guideline for the management of patients on oral anticoagulants requiring dental surgery. Br Dent J 203:389–93.
[2] Becci C, Maglione M, Favero L, Perini A, Di Lenarda R, Berengo M, Zanon E. (2010) Management of dental extraction in patients undergoing anticoagulant treatment. Results from a large, muiticentre, prospective, case-control study. Thromb Haemost. 104;972-975.
[3] Aframian DJ, Lalla RV, Peterson DE. (2007) Management of dental patients taking common hemostasis-altering medications. Oral Sur Oral Med Oral Pathol Oral Radiol Endod 103: e1-11.
[4] Guidelines for Diagnosis and Treatment of Cardiovascular Disease (2008 Joint Working Groups Report). Guidelines for management of anticoagulant and antiplatelet therapy in cardiovascular disease (JCS 2009). http://www.j- circ.or.jp/guideline/pdf/JCS2009_hori_h.pdf (available in December 2015, in Japanese).
[5] JCS Joint Working Group. (2014) Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013). Circ J 78:1997–2021.
[6] Mauprivez C, Khonsari RH, Razouk O, Goudot P, Lesclous P, Descroix V. (2016) Management of dental extraction in patients undergoing anticoagulant oral direct treatment: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol 122:e146-155.
[7] Yoshikawa H, Yoshida M, Yasaka M, Yoshida H, Murasato Y, Fukunaga D, Shintani A, Okada Y. (2019) Safety of tooth extraction in patients receiving direct oral anticoagulant treatment versus warfarin: a prospective observation study. Int J Oral Maxillofac Surg 48:1102-1108.
[8] Evans IL, Sayers MS, Gibbons AJ, Price G, Snooks H, Sugar AW. (2002) Can warfarin be continued during dental extraction? Results of randomized controlled trial. Br J Oral Maxillofac Surg 40:248–52.
[9] Zanon E, Martinelli F, Bacci C, Cordioli G, Girolami A. (2003) Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol. Blood Coagul Fibrinolysis 14:27–30.
[10] Cannon PD, Dharmar VT. (2003) Minor oral surgical procedures in patients on oral anticoagulants—a controlled study. Aust Dent J 48:115–18.
[11] Sacco R, Sacco M, Carpenedo M, Mannucci PM. (2007) Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different intensity targets. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:e18–21.
[12] Morimoto Y, Niwa H, Minematsu K. (2008) Hemostatic management of tooth extractions in patients on oral antithrombotic therapy. J Oral Maxillofac Surg 66:51–7.
[13] Morimoto Y, Niwa H, Yoneda T, Motomura K, Yasaka M, Minematsu K. (2004) Hemostatic management of tooth extraction in patients undergoing antithrombotic therapy. Jpn Stomatol Soc 53:74–80.
[14] Shigeta T, Umeda M, Yoshitake M, Takahashi H, Shibuya Y, Komori T, Ido S, Hasegawa T, Ri S. (2012) A clinical study of hemorrhagic complications in patients with antithrombotic therapy who underwent dental extraction without discontinuation of antithrombotic drugs: 282 patients receiving administration of warfarin. Jpn Stomatol Soc 61:1–7.
[15] Hughes M, Lip GY; Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care. (2007) Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. QJM 100:599–607.
[16] Palareti G, Cosmi B. (2009) Bleeding with anticoagulation therapy—who is at risk, and how best to identify such patients. Thromb Haemost 102:268–78.
[17] Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138:1093–100.
[18] Kataoka T, Hoshi K, Ando T. (2016) Is the HAS-BLED score useful in predicting post-extraction bleeding in patients taking warfarin? A retrospective cohort study. BMJ Open 6:e010471.
[19] Japanese society of Oral and Maxillofacial Surgeons, Japanese Society of Gerodontology, Japanese Society of Dentistry for medically compromised patient. (2015) guidelines for patients on antithrombotic therapy requiring dental extraction. Tokyo: Gakujutsusha Corporation.
[20] Inoue K, Hirao K, Aonuma K, Kumagai K, Kimura M, Miyauchi Y, Tsushima E, Okumura K; JACRE Investigators. (2020) HAS-BLED score as a predictor of bleeding complications from catheter ablation of atrial fibrillation: A subanalysis of the Japanese Anti-Coagulation Regimen Exploration in AF Catheter Ablation Registries. J Cardiol 75:82-89.
[21] Okumura K, Aonuma K, Kumagai K, Hirao K, Inoue K, Kimura M, Miyauchi Y, Tsushima E; JACRE Investigators. (2016) Efficacy and Safety of Rivaroxaban and Warfarin in the Perioperative Period of Catheter Ablation for Atrial Fibrillation - Outcome Analysis From a Prospective Multicenter Registry Study in Japan. Circ J. 80:11.
[22] Samama MM, Contant G, Spiro TE, Perzborn E, Le Flem L, Guinet C, Gourmelin Y, Rohde G, Martinoli JL. (2013) Laboratory assessment of rivaroxaban: a review. Thrombosis J 11:11.
[23] Samama MM, Guinet C. Laboratory assessment of new anticoagulants. (2011) Clin Chem Lab Med 49:761-772.
[24] Hillarp A, Baghaei F, Fagerberg Blixter I, Gustafsson KM, Stigendal L, Sten- Linder M, Strandberg K, Lindahl TL. (2011) Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays. J Thromb Haemost 9:133- 139.
[25] Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P; ESC Scientific Document Group. (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893-2962.
[26] BCGuidelines.ca: Warfarin Therapy – Management During Invasive Procedures and Surgery (2015). https://www2.gov.bc.ca/gov/content/health/practitioner- professional-resources/bc-guidelines/warfarin-during-surgery.
論文の公開元へ
